Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6W1C

Human mAbs broadly protect against infection of arthritiogenic alphaviruses by recognizing conserved elements of the MXR8 receptor binding domain

Summary for 6W1C
Entry DOI10.2210/pdb6w1c/pdb
EMDB information21509
DescriptorE1 glycoprotein, E2 glycoprotein, Fab CHK-265 heavy chain, ... (4 entities in total)
Functional Keywordsvirus, monoclonal antibody, complex, virus-immune system complex, virus/immune system
Biological sourceMayaro virus (strain Brazil) (MAYV)
More
Total number of polymer chains16
Total formula weight505147.79
Authors
Miller, A.S.,Kuhn, R.J. (deposition date: 2020-03-04, release date: 2020-08-26, Last modification date: 2024-03-06)
Primary citationPowell, L.A.,Miller, A.,Fox, J.M.,Kose, N.,Klose, T.,Kim, A.S.,Bombardi, R.,Tennekoon, R.N.,Dharshan de Silva, A.,Carnahan, R.H.,Diamond, M.S.,Rossmann, M.G.,Kuhn, R.J.,Crowe Jr., J.E.
Human mAbs Broadly Protect against Arthritogenic Alphaviruses by Recognizing Conserved Elements of the Mxra8 Receptor-Binding Site.
Cell Host Microbe, 28:699-711.e7, 2020
Cited by
PubMed Abstract: Mosquito inoculation of humans with arthritogenic alphaviruses results in a febrile syndrome characterized by debilitating musculoskeletal pain and arthritis. Despite an expanding global disease burden, no approved therapies or licensed vaccines exist. Here, we describe human monoclonal antibodies (mAbs) that bind to and neutralize multiple distantly related alphaviruses. These mAbs compete for an antigenic site and prevent attachment to the recently discovered Mxra8 alphavirus receptor. Three cryoelectron microscopy structures of Fab in complex with Ross River (RRV), Mayaro, or chikungunya viruses reveal a conserved footprint of the broadly neutralizing mAb RRV-12 in a region of the E2 glycoprotein B domain. This mAb neutralizes virus in vitro by preventing virus entry and spread and is protective in vivo in mouse models. Thus, the RRV-12 mAb and its defined epitope have potential as a therapeutic agent or target of vaccine design against multiple emerging arthritogenic alphavirus infections.
PubMed: 32783883
DOI: 10.1016/j.chom.2020.07.008
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (5.3 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon